Seres Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2016
Total Assets: $272.6M
Liabilities Breakdown FY2016
Total Liabilities: $140.0M
Asset Breakdown
Total Assets: $272.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $54.5M | 20.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $36.1M | 13.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $182.0M | 66.7% |
Liabilities Breakdown
Total Liabilities: $140.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.6M | 5.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $132.4M | 94.6% |